CAS 946525-65-1

Fórmula: C23H25NO5

InChI: InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1

Chave InChI: SENUNDCNOYAWGN-ZQGJOIPISA-N

SMILES: C1CC1C2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C#N

Velagliflozin

CAS: 946525-65-1

Velagliflozin

Fórmula: C₂₃H₂₅NO₅

Pureza: 98%

Peso molecular: 395.45

Ref: 54-OR1112294

Velagliflozin

CAS: 946525-65-1

Fórmula: C₂₃H₂₅NO₅

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 395.4483

Ref: IN-DA01V3RD

Velagliflozin

CAS: 946525-65-1

Velagliflozin is an investigational pharmaceutical compound, which is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is derived from synthetic chemical sources, specifically designed for the modulation of glucose levels in the bloodstream. Velagliflozin functions by inhibiting the SGLT2 protein in the proximal renal tubules, thereby preventing glucose reabsorption in the kidney and promoting its excretion through urine. This mechanism of action effectively lowers blood glucose levels and provides an adjunct therapeutic approach in the management of type 2 diabetes mellitus.

Fórmula: C₂₃H₂₅NO₅

Pureza: Min. 95%

Peso molecular: 395.4 g/mol

Ref: 3D-WMB52565

Velagliflozin

CAS: 946525-65-1

Velagliflozin is an orally available inhibitor of sodium-glucose cotransporter 2.

Fórmula: C₂₃H₂₅NO₅

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 395.4483

Ref: TM-T17221